Returning in November 2019

 Register Your Interest Now

Challenges with Dermatology Clinical Study Endpoints

By Monica Luchi, MD FACR, MBAWyndham Boston Beason Hil


Revolutionize R&D – Provide optimal treatments for patients

By Kim D Kjøller, MD, EVP Global R&D, LEO Pharma


New Horizons in Dermatology: Rare & Orphan Disease Drug Development Opportunities & Challenges 

 By Greg Licholai, MD, President and Chief Scientific Officer, Castle Creek Pharma


Beyond the Hype: Exploring the Application of Biologics to Tackle Unmet Needs in Dermatology

 By Anne Parneix, VP, Senior Global Program Head, Dermatology Therapeutic Area, Novartis


Psoriasis: The Shift in Treatment Paradigm in the Last 25 Years

By Marie Bernasconi, Head of Dermatology Therapeutic Area, Almirall

Capture 2

Collaborative Efforts to Harmonize Endpoints & Outcome Measures in Dermatology

 By Tomoko Maeda-Chubachi, VP, Medical Dermatology, Novan



Capture 3